You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Glycated Albumin and Diabetes: Wave of the Future?

  • Authors: Vivian A. Fonseca, MD, FRCP
  • CME / ABIM MOC Released: 1/11/2021
  • Valid for credit through: 1/11/2022, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for diabetologists & endocrinologists and primary care physicians.

The goal of this activity is to improve awareness of glycated albumin and its clinical importance for management of type 2 diabetes (T2D).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Use of glycated albumin (GA) as a strategy for assessing intermediate glycemic control
  • Have greater competence related to
    • Use of GA to inform clinical practice decisions


As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


  • Vivian A. Fonseca, MD, FRCP

    Assistant Dean for Clinical Research
    Professor of Medicine and Pharmacology
    Chief of the Section of Endocrinology
    Tullis-Tulane Alumni Chair in Diabetes
    Tulane University Health Sciences Center
    New Orleans, Louisiana


    Disclosure: Vivian A. Fonseca, MD, FRCP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Asahi; Bayer HealthCare; Novo Nordisk; Sanofi
    Served as a speaker or a member of a speakers bureau for: Novo Nordisk; Sanofi
    Received grants for clinical research from: Fractyl
    Owns stock, stock options, or bonds from: BRAVO4Health


  • Philippa M. Berman, BA(Hons), MBBS

    Medical Education Director, WebMD Global, LLC


    Disclosure: Philippa M. Berman, BA(Hons), MBBS, has disclosed no relevant financial relationships.

  • Asha P. Gupta, PharmD, RPh

    Senior Scientific Content Manager, Medscape, LLC


    Disclosure: Asha P. Gupta, PharmD, RPh, has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Glycated Albumin and Diabetes: Wave of the Future?

Authors: Vivian A. Fonseca, MD, FRCPFaculty and Disclosures

CME / ABIM MOC Released: 1/11/2021

Valid for credit through: 1/11/2022, 11:59 PM EST


CAD = coronary artery disease
CGM = continuous glucose monitoring
CGMS = continuous glucose monitoring systems
CKD = chronic kidney disease
CVD = cardiovascular disease
DKD = diabetic kidney disease
DM = diabetes mellitus
eGFR = estimated glomerular filtration rate
EPO = erythropoietin
ESA = erythrocyte-stimulating agent
ESRD = end-stage renal disease
FPG = fasting plasma glucose
FRA = fructosamine
GA = glycated albumin
Hb = hemoglobin
HbA1c = glycated hemoglobin
HGI = hemoglobin glycation index
IgG = immunoglobulin G
IMT = intima-media thickness
KM = Kaplan-Meier
MACE = major adverse cardiovascular events
MBG = mean blood glucose
RBC = red blood cell
SMBG = self-monitoring of blood glucose
T1D = type 1 diabetes
T2D = type 2 diabetes

« Return to: Glycated Albumin and Diabetes: Wave of the Future?
  • Print